Apyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature

Dow Jones05-11

By Adriano Marchese

Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction.

Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days.

The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient.

Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

By Adriano Marchese

Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction.

Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days.

The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient.

Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

May 11, 2026 11:44 ET (15:44 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2634016238?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 23:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634016238","market":"hk","top_or_hot":-1,"title":"Apyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction. \n</p>\n<p>\n  Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days. \n</p>\n<p>\n  The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient. \n</p>\n<p>\n  Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction. \n</p>\n<p>\n  Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days. \n</p>\n<p>\n  The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient. \n</p>\n<p>\n  Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 11, 2026 11:44 ET (15:44 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-11 23:21</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction. \n</p>\n<p>\n  Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days. \n</p>\n<p>\n  The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient. \n</p>\n<p>\n  Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 11, 2026 11:21 ET (15:21 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABU","symbol_name":"三倍做多标普生物-Direxion","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2634016238","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2634016238","pubTimestamp":1778512860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction.Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days.The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient.Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LABU":"三倍做多标普生物-Direxion","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4082":"医疗保健设备","APYX":"Apyx Medical Inc"},"translate_title":"FDA扩大对AYON吸脂功能的许可后，Apyx Medical股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":1.5,"APYX":0.9},"content_text":"By Adriano Marchese \n\n\n \n\n\n  Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction. \n\n\n  Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days. \n\n\n  The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient. \n\n\n  Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n\n \n\n\n  By Adriano Marchese \n\n\n \n\n\n  Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction. \n\n\n  Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days. \n\n\n  The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient. \n\n\n  Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 11:44 ET (15:44 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2634016238","isCrawlerRequest":true}